Analyst Opinion Summary: Akers Biosciences, Inc. (AKER), Landmark Infrastructure Partners LP (LMRK)

Akers Biosciences, Inc. (NASDAQ:AKER) tinted gains of +0.38% (+0.01 points) to US$0.9. The volume of 0.16 Million shares climbed down over an trading activity of 422.58 Million shares. EPS ratio determined by looking at last 12 month figures is -3.09. Over the same time span, the stock marked US$5.92 as its best level and the lowest price reached was US$0.57. The corporation has a market cap of US$11.23 Million.

Akers Biosciences, Inc. (NASDAQ:AKER)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as -14.2 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 8.4 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses -12.3 percent gross margin.

Landmark Infrastructure Partners LP (NASDAQ:LMRK) is worth US$396.5 Million and has recently risen 0.38% to US$15.86. The latest exchange of 0.06 Million shares is below its average trading activity of 138.36 Million shares. The stock tapped a 52-week high of US$17.3 while the mean 12-month price target for the shares is US$17.33.

Currently, the stock carries a price to earnings ratio of 4.18, a price to book ratio of 0.98, and a price to sales ratio of 6.12. For the past 5 years, the company’s revenue has grown 30.1%, while the company’s earnings per share has grown 2.59%. With an institutional ownership near 25.2%, it carries an earnings per share ratio of 3.8.